For more than 30 years, Emerging Therapy Solutions® (ETS) has helped payers manage medicine’s most complex, high-cost treatments. Today, we’re applying that experience to cell & gene therapy—and building the infrastructure needed as advanced therapies move from rare events to becoming a more routine part of healthcare.
Organ and stem cell transplantation established the model for managing highly complex, high-cost care. Cell and gene therapies are expanding that challenge with:
Organizations need more than a way to pay the claim. They need:
Today, ETS supports employers, health plans, secondary payers, brokers, providers and patients with the expertise, relationships, analytics and clinical infrastructure needed to manage advanced therapies from risk identification through treatment and outcomes at the best possible price.
The ETS360 Platform brings predictive intelligence, specialized provider navigation, clinical management, patient support and financial strategy together in one integrated framework for transplant, cell & gene therapy and the next generation of advanced treatments.
Predict™
Navigate™
Care™
Protect™Know your actual exposure, guide employees to the highest value care and center, provide expert support and choose the right financial strategy to fit your organization.
Extend your advanced therapy capabilities with predictive intelligence, therapy-specific provider strategies, and specialized clinical management.
See risk earlier, manage the clinical and financial drivers of catastrophic claims, and embed specialized advanced-therapy capabilities into your product.
Help clients understand their actual risk, make better decisions and build the right complex therapy strategy—with the ETS intelligence, expertise and solutions you need.
Our story began more than 30 years ago, when organ transplantation represented some of healthcare’s most complex, high-cost, and unpredictable care. We learned how to build specialized provider networks, guide patients through complex treatment, create transparent financial arrangements, and help payers manage catastrophic risk.
Medicine has changed. The fundamentals of managing complexity have not.
ETS brings that experience to cell and gene therapy and the next generation of advanced treatments.
Discover how the ETS360 Platform
can help you prepare for what’s next.
Copyright © 2026. Emerging Therapy Solutions. All Rights Reserved.
